Tazemetostat

CAS : 1403254-99-8

Ref. 3D-FT165032

Informations sur le produit

• Nom: Tazemetostat
• Synonymes: N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-[1 ,1'-biphenyl]-3-carboxamide

Description

Tazemetostat is an inhibitor that inhibits the activity of a number of enzymes, including transcriptional regulators, histone methyltransferases, and proteases. Tazemetostat has been shown to have significant cytotoxicity in cancer cells and potent antitumor activity against solid tumours in mice. It also has pluripotent-like effects on human embryonic stem cells and can induce differentiation of epithelial mesenchymal progenitor cells into cartilage. Tazemetostat appears to inhibit the transcriptional regulation of collagen synthesis by inhibition of the enzyme collagenase.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 572.74 g/mol
• Formule: C₃₄H₄₄N₄O₄
• Degré de pureté: Min. 95%
• Couleur/Forme: White/Off-White Solid